Literature DB >> 6272278

Reevaluation of the role of gangliosides in the binding and action of thyrotropin.

S K Beckner, R O Brady, P H Fishman.   

Abstract

A cloned line of normal rat thyroid cells, FRTL, contained a small number of high-affinity binding sites for thyrotropin (TSH) when measured under physiological conditions. The cells also bound small amounts of cholera toxin, and both hormone and toxin stimulated cyclic AMP production by the cells. The major ganglioside of FRTL cells was N-acetylneuraminylgalactosylglucosylceramide (GM3), with minor amounts of gangliosides corresponding to galactosyl-N-acetylgalactosaminyl-[N-acetyl-neuraminyl]-galactosylglucosylceramide (GM1) and N-acetylneuraminylgalactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GD1a). Treatment of these cells with neuraminidase (acylneuraminyl hydrolase, EC 3.2.1.18) converted most of the GD1a to GM1. After neuraminidase treatment, the binding of cholera toxin, which binds to GM1, was increased, but there was no change in the binding of TSH. Preincubation of neuraminidase-treated FRTL cells with the B (binding) component of cholera toxin completely prevented cholera toxin binding but had no effect on the binding of TSH. Neuraminidase treatment also somewhat enhanced, rather than decreased, the cyclic AMP response to TSH. Pretreatment of FRTL cells with mixed brain gangliosides resulted in a 10-fold increase in cholera toxin binding. Again there was no enhancement of TSH binding or adenylate cyclase stimulation. Finally, prolonged exposure of FRTL cells to TSH induced down-regulation of TSH receptors but had no effect on gangliosides or cholera toxin receptors. The results indicate that more complex gangliosides do not serve as a component of the TSH receptor nor are they involved in the transmission of the hormone signal across the cell membrane of these cultured rat thyroid cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272278      PMCID: PMC320271          DOI: 10.1073/pnas.78.8.4848

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes.

Authors:  R L Tate; J M Holmes; L D Kohn; R J Winand
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

2.  Uptake and metabolism of gangliosides in transformed mouse fibroblasts. Relationship of ganglioside structure to choleragen response.

Authors:  P H Fishman; J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1976-08-10       Impact factor: 5.157

3.  Thyrotropin receptors on bovine thyroid membranes: two types with different affinities and specificities.

Authors:  F Pekonen; B D Weintraub
Journal:  Endocrinology       Date:  1979-08       Impact factor: 4.736

4.  Abnormal adenylate cyclase activity and altered membrane gangliosides in thyroid cells from patients with Graves' disease.

Authors:  G Lee; E F Grollman; S M Aloj; L D Kohn; R J Winand
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

5.  Effect of thyroid phospholipids on the interaction of thyrotropin with thyroid membranes.

Authors:  F Omodeo-Sale; R O Brady; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Role of carbohydrates in thyrotropin binding sites.

Authors:  F Pekonen
Journal:  Horm Metab Res       Date:  1980-07       Impact factor: 2.936

7.  Dansylated thyrotropin as a probe of hormone-receptor interactions.

Authors:  S M Aloj; G Lee; E Consiglio; S Formisano; A P Minton; L D Kohn
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

8.  Effects of thyrotropin and cholera toxin on the thyroidal adenylate cyclase-adenosine 3',5'-monophosphate system.

Authors:  S D Holmes; G Titus; M Chou; J B Field
Journal:  Endocrinology       Date:  1980-12       Impact factor: 4.736

9.  Enzymatic and chemical oxidation of gangliosides in cultured cells: effects of choleragen.

Authors:  J Moss; V C Manganiello; P H Fishman
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

10.  Properties of the interaction between bovine thyrotropin and bovine thyroid plasma membranes.

Authors:  S M Amir; I D Goldfine; S H Ingbar
Journal:  J Biol Chem       Date:  1976-08-10       Impact factor: 5.157

View more
  7 in total

1.  Gangliosides and phospholipids in human thyroids responsive and unresponsive to thyrotropin.

Authors:  A Mariano; A Di Carlo; P E Macchia; G Pisano; U Parmeggiani; V Macchia
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

2.  Mechanism of action of glycopeptide hormones and cholera toxin: what is the role of ADP-ribosylation?

Authors:  R V Rebois; S K Beckner; R O Brady; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

3.  Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.

Authors:  W A Valente; Z Yavin; E Yavin; E F Grollman; M Schneider; C M Rotella; R Zonefrati; R S Toccafondi; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

Review 4.  Role of membrane gangliosides in the binding and action of bacterial toxins.

Authors:  P H Fishman
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

5.  Effects of thyrotropin and thyroid stimulating immunoglobulins on gangliosides labelling of human thyroid cultured pathological cells.

Authors:  J Etienne-Decerf; C Gosselin-Rey; L Gosselin; R Winand
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

6.  Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin.

Authors:  S Kellie; B Patel; E J Pierce; D R Critchley
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

Review 7.  Membrane receptors for bacterial toxins.

Authors:  L Eidels; R L Proia; D A Hart
Journal:  Microbiol Rev       Date:  1983-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.